Mariah Carey drops first solo music in 6 years
Mariah Carey has dropped her first solo music in six years, Type Dangerous.
After teasing fans about her 16th studio album with a glamourous sports car teaser on social media, fans have been given the first taste of what's to come.
Type Dangerous samples legendary hip-hop trio Eric B. and Rakim's 1986 cut Eric B. Is President.
In a statement, Mariah said of her return: "I've been locked up in the studio for quite some time working my behind off on new music, and I'm thrilled for the unveiling of it to my fans, starting with Type Dangerous!"
Mariah's new album will mark her first since 2018's Caution.
The new song comes after Anderson Paak recently revealed he's been working on new music with Mariah.
The 39-year-old singer-and-producer let the news slip while appearing on social media series Track Star — where guests try to identify mystery songs — and he correctly guessed the 56-year-old star's 1996 track Always Be My Baby.
Anderson — who was wearing a T-shirt featuring Mariah's face — said: "This would be Mariah Carey. The Mariah Carey.
"I remember in like 5th grade, or something, watching the music videos and having a huge crush. We're working on some music on her new album."
The pair hooking up in the studio comes after the pair were romantically linked in March 2025 when they were seen holding hands after the iHeartRadio Music Awards and were also spotted leaving a restaurant together around the same time.
Last year saw Mariah celebrate 20 years since the release of her Emancipation of Mimi album.
[[nid:718753]]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
5 minutes ago
- Daily Mail
John Fetterman snubs wife Giselle on their own wedding anniversary as he dines with MAGA power player
Democratic Sen. John Fetterman was spotted out to dinner with a MAGA icon at a conservative hotspot in Washington - apparently on his wedding anniversary. The senator who has made a name for himself for bucking his party was spotted dining with a Breitbart reporter on Monday, June 9th, Politico reported. But that's not what caused the online stir. What left onlookers gobsmacked about the weeknight dinner was a brief visit from former Trump advisor and MAGA strategist Steve Bannon, the conservative fireband and liberal bogeyman who anchors his own influential 'War Room' podcast. More stunningly, that dinner at Butterworth's - a buzzy Capitol Hill bistro known to attract MAGA socialites and GOP Hill staffers - apparently happened on Fetterman's 17th anniversary. However, the senator's wife, Gisele, was not mentioned in the dispatch about the surprising dinner party. 'John Fetterman, the not-uncontroversial Democratic senator for Pennsylvania, dining in D.C.'s top MAGA hangout Butterworth's ... Fetterman was joined by Breitbart's Matt Boyle, plus — for a good 20 minutes or so — Steve Bannon,' the outlet wrote. Fetterman's office did not respond to a request for comment from the Daily Mail. The potential dinner snub comes after Senate staffers told the Daily Mail in May that Gisele has been absent from Washington this year. A New York Magazine report around that time also documented how Gisele has been concerned with her husband's behavior, including his support for Israel. Fetterman, 55, once believed to be the pro-union, socialist assumed heir to Bernie Sanders ' far-left platform, has since the October 7 attack been leaning more rightward, fervently supporting Israel and denouncing the 'progressive' moniker. He has met personally with President Donald Trump and broken ranks with Democrats with his support for strict border and immigration restrictions as well as fracking, the controversial method to extract oil and gas from the ground. As Fetterman has slid from pseudo-progressive to Democratic populist his staffers have expressed concern over the senator's health and behavior. The 55-year-old suffered a stroke during his 2022 campaign and soon after joining Congress checked himself into the hospital as he battled depression. The bombshell New York Mag piece on the senator lifted the veil on many personal details regarding the Democrat's health struggles, including sections about Gisele complaining to her husband's staff and doctors locking him out of his social media as he underwent treatment. The Democrat and many senators slammed the article at the time. Fetterman told the Daily Mail the report was a 'hit piece.' In the days after the piece was published, multiple staffers told the Daily Mail that Gisele had not been spotted around her husband's Senate office recently. But when Gisele was spotted not wearing her wedding ring in early May, she told the Daily Mail that she was not wearing it because she is a firefighter. 'I'm a firefighter, did you know that? If I wore my wedding ring to fight fires, that would be dangerous,' she said. 'That's why it's not here.' Shortly after the news broke that Fetterman and Bannon dined together briefly on June 9th, X users pieced together that dinner occurred on what Fetterman has said is his anniversary with Gisele. Fetterman posted on June 10, 2024 that he and Gisele had gotten in a car accident 'yesterday,' noting it was a bad way to spend their 'anniversary.' So his sit-down at a MAGA hub with Bannon a year later on his anniversary has raised questions and criticism online. 'OH MY GODDDDD,' one X user reacted to the senator's anniversary plans. You might have heard G and I were in a car accident yesterday. Thank you all for the well wishes. Not the best way to spend our 16th wedding anniversary but we're doing well and happy to be back home in Braddock with the family. — U.S. Senator John Fetterman (@SenFettermanPA) June 10, 2024 'On his 17th wedding anniversary, John Fetterman was seen dining at D.C.'s top MAGA hangout,' Howie Klein, a progressive blogger, wrote on X. 'At the rate he's going, he'll be eligible for Gavin Newsom's podcast soon!' he said of the California governor's show that frequently features Republican guests.
NBC Sports
5 minutes ago
- NBC Sports
Mets lefty David Peterson pitches his first 9-inning complete game since college in 2017
NEW YORK — David Peterson had just walked back to the dugout after eight innings and 97 pitches when New York Mets manager Carlos Mendoza approached him. 'Kind of pulled me aside and said let's have a talk and wanted to hear what I had to say,' Peterson would later recall. He strolled into the tunnel toward the clubhouse for a quick talk with Mendoza and pitching coach Jeremy Hefner. 'I told them let me finish this thing,' the 29-year-old left-hander said. Peterson returned to the mound and polished off a six-hitter for the first nine-inning complete game of his professional career, a 5-0 victory over the Washington Nationals on Wednesday night that stretched New York's winning streak to five. 'He came in the dugout and he didn't want to give me a look,' Mendoza said. 'That for me is a sign that he wants to go back out.' Their tunnel conversation was brisk. Ryne Stanek was warming up in the bullpen, just in case. 'I said, `Man, this is a tough one,'' Mendoza remembered. 'You've only got a few pitches here.' It was like: `Let me finish it.' I said: `All right, it's yours.'' Mendoza emphasized the short leash to catcher Luis Torrens. 'He says, `Hey, he's got about eight or nine pitches,'' Torrens related through a translator, 'so I went out there with the plan to be able to get a quick ninth.' Fans in the Citi Field crowd of 40,681 roared when Peterson rushed back to the mound for the ninth. He fell behind Amed Rosario 2-0 before retiring him on a lineout, struck out slugger James Wood on three pitches and retired Andrés Chaparro on a groundout with his 106th pitch, ending a game that took just 2 hours, 16 minutes. Peterson pumped a fist, flashed the widest of smiles and hugged Torrens and then Pete Alonso. The first baseman handed Peterson the ball, which the pitcher promptly tucked into a rear pocket in his pants. A dozen Mets formed a circle, arms over shoulders, and each raised a knee quickly in their goofy group celebration. 'It's been fun to see him grow up in front of my eyes,' said outfielder Brandon Nimmo, who homered twice. 'I was here when he first came up and everybody's kind of trying to feel their way around and kind of make sure they belong in the big leagues. And then now to see him the way that he is and him take the field with such confidence and knowing that if he executes his plan, he's really hard to hit.' Peterson struck out six and walked none, throwing 75 of 106 pitches for strikes and opening with a strike to 21 of 32 batters. He mixed 30 fastballs, 29 sinkers, 27 sliders, 11 changeups and nine curveballs, getting 13 swings and misses. 'He kept us off balance,' Nationals manager Dave Martinez said. Peterson's only prior professional complete game was a four-hitter in a rain-shortened, five-inning loss to Atlanta on April 28, 2023. His previous nine-inning complete game came in college, a four-hit shutout for Oregon against Arizona State on April 28, 2017. Selected by the Mets with the 20th overall pick in that year's amateur draft, Peterson signed for a $2,994,500 bonus. He won his debut three years later at Fenway Park early in the pandemic-shortened season and was 18-21 with a 4.51 ERA in his first four seasons, getting optioned back to Triple-A Syracuse five times in 2022 and twice more in 2023. He had surgery on Nov. 6, 2023, to repair a torn labrum in his left hip, delaying his 2024 debut until May 29. He is 15-5 with a 2.74 ERA since. Last October, he was moved to the bullpen and got the final three outs of the Division Series clincher at Milwaukee. 'The compete, how much he wants it, his ability to come through in big moments,' Mendoza explained, 'I can sit here and say a lot of different things about him, but he's just a guy that the situation is never too big for.' In an age of analytics that has made bullpen use paramount, Peterson pitched the seventh shutout and 14th complete game in the major leagues this season. The Mets hadn't thrown a complete game since Luis Severino's shutout against Miami last Aug. 17 and they hadn't gotten a shutout from a left-hander since Steven Matz vs. Pittsburgh on July 27, 2019. 'When you have to work for something, and when it doesn't come easy, it means all that much more,' Nimmo said. 'He was a first-round pick, and you have a lot of expectations that come with you with that. But he stayed the process, and he's worked hard and taken advantage of that talent.'
Yahoo
5 minutes ago
- Yahoo
Apex Labs Granted Israel MoH Approval to Expand Phase 2b Macrodose Psilocybin PTSD Clinical Trial
Israel's Ministry of Health (MoH) approval to add additional sites to APEX SUMMIT-90 160 patient phase 2b macrodose clinical trial: Tel Aviv University (TAU)'s Institute for Psychedelic Research located at the Sagol Brain Institute (SGI) in Tel-Aviv Sourasky Medical Center. Be'er Yaakov Mental Hospital (Merhavim) Center for Psychedelic Studies. For more information or to register visit (Canada) and (Israel). VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming the standard of mental health care with psilocybin is pleased to announce the approval by the Israeli MoH and IRBs to open two additional clinical trial sites for SUMMIT-90. The trial is a double-blind, placebo controlled phase 2b study evaluating multiple doses of APEX-90, a psilocybin macrodose utilizing APEX's US patent pending capsule. APEX-90 is administered in-clinic with study-assisted psychotherapy for severe depression within diagnosed PTSD. Israel is facing a severe mental health crisis: 44% of adults report depression and 42% PTSD, far above the 8–13% depression and 6–10% PTSD rates seen in the US and Canada. This MoH approval leverages the expertise of TAU's renowned SGI and Merhavim Hospital, which both have a rich history of pioneering research in neurological sciences. Their cutting-edge facilities and teams profound understanding of PTSD dynamics are poised to add patient recruitment expertise. 'I am honoured to have been able to facilitate this new partnership; another example of building important bridges between Canada and Israel in innovative clinical research, which will result in advancing patient access to emerging treatments,' says Sharon J. Fraenkel, TAU Canada's CEO for Ottawa, Quebec, and Atlantic Canada, on behalf of the organization. 'As someone deeply connected to Israel, witnessing the toll of PTSD among my loved ones, I'm driven to lead research that brings hope and healing,' says Alysa Langburt, APEX's VP of Global Clinical Development. 'This marks more than a clinical milestone, it represents a fundamental step towards transforming the mental health landscape in Canada and Israel, where the need has never been greater. Through our incredible partnerships, we aim to catalyze a shift in access, care and outcomes for those suffering with PTSD.' "SUMMIT-90 offers a beacon of hope for the significant numbers suffering from PTSD in Canada and Israel,' says Tyler Powell, co-Founder and CEO of APEX. 'It underscores our commitment to global mental health innovation and our belief in the opportunity for clinically proven psilocybin therapies to transform mental health care.' About Apex Labs is a patient-driven pharmaceutical company focused on revolutionizing the standard of mental health care with psilocybin. APEX's strategy is two-pronged, clinical evaluation of drug assets alongside a robust Early Access Program. APEX recognizes and prioritizes Veterans as a patient base with the most severe unmet medical need. Visit for more information and follow APEX on LinkedIn, Twitter and Instagram. Forward-Looking StatementsThis release contains certain "forward-looking statements" and certain "forward-looking information" as defined under applicable Canadian securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as "may", "will", "expect", "intend", "estimate", "anticipate", "believe", "continue", "plans" or similar terminology. Forward-looking statements and information are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that, while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability to control or predict, that may cause the Company's actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out here in, including but not limited to: receiving authorization of Health Canada Dealers Licence; filing US provisional patent, the Company evaluating the safety and efficacy of APEX-52 (psilocybin) and APEX-90 (psilocybin) in treating depression in Veterans and patients with Post-Traumatic Stress Disorder; statements related to APEX-52 and APEX-90, including manufacturing, dosing, and trial details; statements made by the Company's executives with respect to Health Canada's Dealer's Licence and capsule patent filing; the Company's efforts around the Early Access Program; statements made relating to Canadian Veteran patients; approvals by the Israeli Ministry of Health and ethics; the inherent risks involved in the general securities markets; uncertainties relating to the availability and costs of financing needed in the future; the inherent uncertainty of cost estimates and the potential for unexpected costs and expenses, currency fluctuations; regulatory restrictions, liability, competition, loss of key employees and other related risks and uncertainties. The Company undertakes no obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents managements' best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information. SOURCE Apex Labs Ltd. CONTACT: For further information: info@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
